ArticleFrontiers in oncology2022

A Lung Cancer Patient Harboring a Rare Oncogenic EGFR Exon 20 V786M Mutation Responded to a Third-Generation Tyrosine Kinase Inhibitor: Case Report and Review of the Literature.

Qi Zhu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.